West Pharmaceutical Services West Vantage — Total Assets increased by 3.0% to $739.60M in Q1 2026 compared to the prior quarter.
An increase may signal expansion or investment in capacity, while a decrease could indicate asset divestiture or improved capital efficiency.
This metric measures the total book value of assets specifically allocated to or utilized by the West Vantage segment. I...
Comparable to segment-specific asset bases reported by diversified industrial or healthcare supply companies.
wst_segment_west_vantage_assets| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $718.10M | $739.60M |
| QoQ Change | — | +3.0% |